Renin-Angiotensin System Blocker Fetopathy

Overview

Journal J Pediatr

Specialty Pediatrics

Date 2015 Aug 10

PMID 26254838

Citations 6

Authors

Janet D Cragan

Bessie A Young

Adolfo Correa

Affiliations

Soon will be listed here.

Citing Articles

Approach to the Patient: Reninoma.

Hayes A, Stowasser M, Umapathysivam M, Falhammar H, Torpy D J Clin Endocrinol Metab. 2023; 109(2):e809-e816.

PMID: 37647894 PMC: 10795928. DOI: 10.1210/clinem/dgad516.

Adverse Impact of Environmental Chemicals on Developmental Origins of Kidney Disease and Hypertension.

Hsu C, Tain Y Front Endocrinol (Lausanne). 2021; 12:745716.

PMID: 34721300 PMC: 8551449. DOI: 10.3389/fendo.2021.745716.

Animal Models for DOHaD Research: Focus on Hypertension of Developmental Origins.

Hsu C, Tain Y Biomedicines. 2021; 9(6).

PMID: 34072634 PMC: 8227380. DOI: 10.3390/biomedicines9060623.

Programming of Renal Development and Chronic Disease in Adult Life.

Lumbers E, Kandasamy Y, Delforce S, Boyce A, Gibson K, Pringle K Front Physiol. 2020; 11:757.

PMID: 32765290 PMC: 7378775. DOI: 10.3389/fphys.2020.00757.

When Less or More Isn't Enough: Renal Maldevelopment Arising From Disequilibrium in the Renin-Angiotensin System.

Almeida L, Coimbra T Front Pediatr. 2019; 7:296.

PMID: 31380328 PMC: 6650528. DOI: 10.3389/fped.2019.00296.

References

Kallen B, Olausson P . Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol. 2003; 17(3):255-61. DOI: 10.1016/s0890-6238(03)00012-1. View

Guron G, Friberg P . An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens. 2000; 18(2):123-37. DOI: 10.1097/00004872-200018020-00001. View

Osterman M, Martin J, Mathews T, Hamilton B . Expanded data from the new birth certificate, 2008. Natl Vital Stat Rep. 2011; 59(7):1-28. View

Raio L, Bolla D, Baumann M . Hypertension in pregnancy. Curr Opin Cardiol. 2015; 30(4):411-5. DOI: 10.1097/HCO.0000000000000190. View

Bateman B, Huybrechts K, Fischer M, Seely E, Ecker J, Oberg A . Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. Am J Obstet Gynecol. 2014; 212(3):337.e1-14. PMC: 4346443. DOI: 10.1016/j.ajog.2014.09.031. View

James P, Oparil S, Carter B, Cushman W, Dennison-Himmelfarb C, Handler J . 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2013; 311(5):507-20. DOI: 10.1001/jama.2013.284427. View

Tylicki L, Lizakowski S, Rutkowski B . Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions. J Nephrol. 2012; 25(6):900-10. DOI: 10.5301/jn.5000134. View

Mosher W, Jones J, Abma J . Intended and unintended births in the United States: 1982-2010. Natl Health Stat Report. 2012; (55):1-28. View

Nadeem S, Hashmat S, DeFreitas M, Westreich K, Shatat I, Selewski D . Renin Angiotensin System Blocker Fetopathy: A Midwest Pediatric Nephrology Consortium Report. J Pediatr. 2015; 167(4):881-5. DOI: 10.1016/j.jpeds.2015.05.045. View

10.

Friberg P, Sundelin B, Bohman S, Bobik A, Nilsson H, Wickman A . Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int. 1994; 45(2):485-92. DOI: 10.1038/ki.1994.63. View

11.

Shotan A, Widerhorn J, Hurst A, Elkayam U . Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med. 1994; 96(5):451-6. DOI: 10.1016/0002-9343(94)90172-4. View

12.

Cooper W, Hernandez-Diaz S, Arbogast P, Dudley J, Dyer S, Gideon P . Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006; 354(23):2443-51. DOI: 10.1056/NEJMoa055202. View

13.

. Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep. 2008; 57(1):1-5. View

14.

Lennestal R, Olausson P, Kallen B . Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol. 2009; 65(6):615-25. DOI: 10.1007/s00228-009-0620-0. View

15.

Caton A, Bell E, Druschel C, Werler M, Lin A, Browne M . Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension. 2009; 54(1):63-70. PMC: 4913772. DOI: 10.1161/HYPERTENSIONAHA.109.129098. View

16.

Bateman B, Bansil P, Hernandez-Diaz S, Mhyre J, Callaghan W, Kuklina E . Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2011; 206(2):134.e1-8. PMC: 4103984. DOI: 10.1016/j.ajog.2011.10.878. View

17.

Bateman B, Shaw K, Kuklina E, Callaghan W, Seely E, Hernandez-Diaz S . Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS One. 2012; 7(4):e36171. PMC: 3340351. DOI: 10.1371/journal.pone.0036171. View

18.

Bullo M, Tschumi S, Bucher B, Bianchetti M, Simonetti G . Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension. 2012; 60(2):444-50. DOI: 10.1161/HYPERTENSIONAHA.112.196352. View